Codexis Inc (CDXS) - Market Cap to Earnings

Codexis Bio - graphic logo of issuer CDXS

Codexis, Inc. (CDXS) develops industrial enzymes, helping partners reduce energy costs and harmful emissions as part of ESG initiatives. The price history on the GURU.Markets chart shows a value of -4.00. California-based production is scaling via third-party contractors to optimize expenses. Meanwhile, Codexis, Inc. (CDXS) focuses on strict compliance with laboratory waste disposal regulations, maintaining a minimal direct carbon footprint.

Codexis - CDXS P/E Multiple (period 07/04/2022 - 11/10/2026)

Analytical breakdowns for Codexis Inc (CDXS)

- current price and projected stock value:
Share Price Codexis Bio|CDXS - Analyst Consensus Forecast
- market capitalization indicators:
Market Value Codexis|CDXS - Real Price to Acquire Entire Company
- book value of equity indicators:
Equity per Share Codexis, Inc.|CDXS - Book Capitalization|Market Capitalization to Book Value codexis.com|CDXS - Aggregate Company Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Codexis, Inc.|CDXS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Codexis Bio|CDXS - Company Aggregate Debts|Debts to Net Assets Codexis|CDXS - Company Long-Term Debt|Company Short-Term Indebtedness Codexis, Inc.|Quick Liquidity Indicator codexis.com
- financial results and valuation multiples details:
CDXS - Net Income|Company Profit Forecast Codexis, Inc.|CDXS - P/E Multiple|Projected Price to Earnings Codexis Bio|CDXS - PEG Multiple|Enterprise Value to Operating Income Before Depreciation Codexis|CDXS - Operating profit before deduction of amortization|Earnings per share for the last 12 months Codexis, Inc.|CDXS - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months codexis.com|CDXS - Earnings growth in current year|Projected earnings per share growth rate for next year Codexis, Inc.
Summary company analysis:Codexis, Inc.
Manufactured product of Codexis, Inc.

The ratio of Codexis, Inc. (CDXS) market value to its net income determines the business's ceiling price, separating objective figures from market expectations. Analyzing the company's P/E dynamics allows an investor to assess the asset's vulnerability to macroeconomic shocks and regulatory risks. This chart captures the balance between potential returns and the probability of a price drawdown. The stability of this ratio is supported by the reliability of diversified bioenzyme supply chains.

Analysis of competing companies

Price to Earnings Multiple TEM (Tempus AI Inc)|P/E Multiple QGEN|IONS - Market Cap to Earnings|Repligen Corp. - Price to Earnings Ratio|RNA: Price to Earnings Multiple|CRISPR Therapeutics AG - P/E Multiple|Business Payback Period genedx.com WGS|Ultragenyx (RARE) - Price to Earnings Ratio|BEAM - Business Payback Period|Price to Earnings Ratio SRPT|TWST: Company Value to Net Income|P/E Multiple TXG|Business Payback Period intelliatx.com|Price to Earnings Ratio Stoke Therapeutics, Inc. STOK|BLFS: Price to Earnings Multiple|Wave Life Sciences Corp - P/E Multiple|Maze Therapeutics Corp (MAZE) - Price to Earnings Ratio|SION (Sionna Therapeutics Inc) - Price to Earnings Ratio|PRME - Business Payback Period|TSHA (Taysha Gene Therapies, Inc.) - P/E Multiple|Price to Earnings Ratio uniQure NV (QURE)|P/E Multiple MGTX|REGENXBIO Corp - Price to Earnings Multiple|Solid Biosciences Inc. - Price to Earnings Ratio|OCGN: Price to Earnings Multiple|PACB - Price to Earnings Ratio|Business Payback Period Benitec Biopharma Inc BNTC|DSGN: P/E Multiple|Price to Earnings Multiple RCKT|Price to Earnings Ratio 4D Molecular Therapeutics|Price to Earnings Multiple LXEO (Lexeo)|P/E Multiple KRRO|P/E Multiple Editas Medicine Inc (EDIT)|P/E Multiple SLN (Silence Therapeutics Inc.)|PRQR - Price to Earnings Ratio|SGMO - Price to Earnings Ratio|Market Cap to Earnings Nautilus Biotechnology|MGX: P/E Multiple|Price to Earnings Multiple DTIL|GBIO (Generation Bio Co) - P/E Multiple|Market Cap to Earnings Boundless Bio Inc BOLD|Price to Earnings Ratio XCUR (Exicure, Inc.)|imunon.com - Price to Earnings Multiple|P/E Multiple PHIO (Phio Pharmaceuticals Corp.)|Business Payback Period Mustang Bio Inc (MBIO)|RNAZ - Price to Earnings Ratio|Business Payback Period Bionano Genomics, Inc. BNGO|APDN (Applied DNA Sciences) - Price to Earnings Ratio|bluebirdbio.com - Company Value to Net Income|IPA (ImmunoPrecise Antibodies Ltd) - P/E Multiple|Omega Therapeutics Inc (OMGA) - Business Payback Period|Price to Earnings Ratio Singular Genomics Systems Inc (OMIC)|Regulus - Price to Earnings Multiple|P/E Multiple SYRS (Syros Pharmaceuticals)|TBIO - Price to Earnings Ratio|TCON: Price to Earnings Ratio|Business Payback Period Unity Biotechnology Inc. UBX